Artículos científicos Open Access
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
Li, T., Xue, W., Zheng, Q. et al.
Nature Communications
Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues
Martin, G., Wolf, J., Lapp, T. et al
Scientific Reports
Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy
Kashani-Ligumsky, L., Lopian, M., Cohen, R. et al
Journal of Perinatology
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma
Geng, J., Chen, L., Yuan, Y. et al.
Signal Transduction and Targeted Therapy
The origins of viruses: discovery takes time, international resources, and cooperation
Yigang Tong, et al
The Lancet
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
Utkarsh Agrawal, et al
The Lancet Respiratory Medicine
Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
Eyal Leshem, et al
The Lancet Respiratory Medicine
The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilities
Dinesh Aggarwal, et al
The Lancet Microbe
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
David M. Weinreich, et al
NEJM
